Welcome to the Pre-Palooza Page for CPQCC's (virtual) Improvement Palooza 2021: Advancing Anti-Racism in the NICU Through Teamwork and Family-Centeredness. Below you will find information and exercises that will help you make the most of your time at our virtual Improvement Palooza on March 5, 20201. This page will be continuously updated as we get closer to Improvement Palooza, so keep checking back for more information!
Keynote Panel: Practicing Anti-Racism to Improve Outcomes for Black Infants
Moderator: Carmin Powell, MD
Dr. Carmin Powell is a Clinical Assistant Professor of Pediatrics at the Stanford University School of Medicine and the Site Director for Pediatric Hospitalists at Watsonville Community Hospital. Dr. Powell is passionate about increasing the recruitment and retention of underrepresented minority (URM) physician leaders at all levels of academic medicine, using her skills, expertise, and networks to further this mission. She serves as the Co-Founder and Co-Director of the Leadership Education in Advancing Diversity (LEAD) Program at Stanford Medicine, which won the Stanford University President’s Award for Excellence through Diversity. In her clinical role at Watsonville Community Hospital, she oversees a team of pediatric hospitalists and implements strategic efforts to improve clinical pediatric and newborn care in a community setting.
Dr. Powell completed her medical education at The Ohio State University College of Medicine, and her residency and chief residency at Stanford Children’s Health, Lucile Packard Children’s Hospital Stanford.
Rachel R. Hardeman, PhD, MPH
Dr. Rachel R. Hardeman is a tenured Associate Professor in the Division of Health Policy & Management, University of Minnesota, School of Public Health and the Blue Cross Endowed Professor in Health and Racial Equity. A reproductive health equity researcher, she applies the tools of population health science and health services research to elucidate a critical and complex determinant of health inequity—racism. Dr. Hardeman leverages the frameworks of critical race theory and reproductive justice to inform her equity-centered work, aiming to build the empirical evidence of racism’s impact on health, particularly for Black birthing people and their babies. Her work also examines the potential mental health impacts for Black birthing people when living in a community that has experienced the killing of an unarmed Black person by police.
Published in journals such as the New England Journal of Medicine and the American Journal of Public Health, Dr. Hardeman’s research has elicited important conversations on culturally-centered care, police brutality, and structural racism as a fundamental cause of health inequities.
Dr. Hardeman earned an undergraduate degree in chemistry and Spanish from Xavier University of Louisiana, an MPH in Public Health Administration and Policy, and a Ph.D. in Health Services Research and Policy from the University of Minnesota School of Public Health.
Tamorah Lewis, MD, PhD
Dr. Tamorah Lewis, currently based at Children’s Mercy Hospital in Kansas City, MO, has been a physician-scientist practicing in academic medicine since 2014. She is active in clinical medicine, research, and teaching the next generation of physicians. She is passionate about improving racial health equity and eliminating health injustice. Dr. Lewis is dually trained in neonatal/perinatal medicine and clinical pharmacology. Her research program focuses on developmental pharmacology and pharmacogenetics in the neonatal population. As an Associate Professor in the Department of Pediatrics at The University of Missouri, Kansas City School of Medicine, she practices clinical neonatology and works collaboratively to design, implement, and manage her clinical and translational research program in Neonatal Precision Therapeutics.
Dr. Lewis serves as the Director of Clinical Research Logistics for her Division. She has established the Maternal Neonatal Pharmacogenetic Repository at Children’s Mercy Hospital and has multiple prospective pharmacogenetic cohort studies enrolling and depositing diverse bio-samples to this repository. In addition, she has established research collaborations at UCSF (steroid pharmacogenetics), Vanderbilt (ductus arteriosus pharmacogenetics), and Univ of Buffalo (NSAID PK) and is actively engaged as site PI in multi-site studies assessing neonatal drug safety and efficacy.
Dr. Lewis is actively engaged in research societies. She sits on the Board of Directors for the American Society of Clinical Pharmacology and Therapeutics and is on the Executive Committee of the American Academy of Pediatrics (AAP) Section on Clinical Pharmacology and Therapeutics. Dr. Lewis is also a member of the International Neonatal Consortium, a multi-stakeholder collaboration run by the Critical Path Institute to advance neonatal therapeutics.